These WHO interim recommendations on the use of the ChAdOx1-S [recombinant] vaccine against Covid-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE).
Additional information:
|